Clinical & Experimental Metastasis

, Volume 29, Issue 7, pp 699–706

Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

Research Paper

DOI: 10.1007/s10585-012-9503-3

Cite this article as:
Morton, D.L. Clin Exp Metastasis (2012) 29: 699. doi:10.1007/s10585-012-9503-3

Abstract

This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.

Keywords

MelanomaSentinel node biopsyMicrometastasesLymphatic mappingPhase III multicenter trial

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.John Wayne Cancer InstituteSanta MonicaUSA